Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 98Breast 47Thoracic 43Gastrointestinal 42Genitourinary 23Lymphoid 21Gynecologic 21Head & Neck 17Other hematologic neoplasm 12Plasma cell 11Tumor-Agnostic 10Dermatologic 9Sarcoma 7Endocrine 5Myeloid 4CNS 4Other 3NET 2Classical hematology 2Other neoplasm 1

Conditions

Stomatitis 3Mucositis 3Head and Neck Neoplasms 3Mouth Neoplasms 2Carcinoma, Squamous Cell 1

Interventions

naloxegol 7alvimopan 6Radiotherapy 5angiotensin I (1-7) 4Cisplatin 4tegaserod 3Injections 3RRx-001 2Fibroblast Growth Factor 7 2tempol 1prucalopride 1oxycodone naloxone combination 1naldemedine 1methylnaltrexone 1linaclotide 1licogliflozin 1hydrated silica gel-based toothpaste 1golotimod 1brilacidin 1apraglutide 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Water 1Therapeutics 1Testosterone Propionate 1Robotic Surgical Procedures 1Radiotherapy, Intensity-Modulated 1Phenylephrine 1Oxycodone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Injections × Other × Clear all
NCT05966194 2024-11-15

KEVLARx

EpicentRx, Inc.

Phase 2 Recruiting
216 enrolled
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03515538 2024-11-04

PREVLAR

EpicentRx, Inc.

Phase 2 Completed
53 enrolled 15 charts
Head & NeckOther

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡